OKUR compared with QTTB: revenue, margins and what each company keeps, and the suppliers and customers both name

OKUROnKure Therapeutics, Inc.

Mkt capRevenueRevenue

QTTBQ32 Bio Inc.

Mkt capRevenueRevenue

Compare

OKUROnKure Therapeutics, Inc.

QTTBQ32 Bio Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

OKUR1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±80.0%▲+1.46%×0.02

QTTB1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±16.2%▲+2.07%×0.13

= impliedOKUR realized, solidQTTB realized, hatchedOne scale, both sides: full bar = 80%× = |realized| ÷ impliedSource: market data

OKUROnKure Therapeutics, Inc.

2.63▲+0.50%· post 2.63

Mkt cap$106.1MRevenue—

QTTBQ32 Bio Inc.

8.91▲+0.47%· post 9.00

ClosedOct 30 '26

Mkt cap$265.2MRevenue$54MQ4 FY25

Compare

ClosedOct 30 '26

OKUROnKure Therapeutics, Inc.

QTTBQ32 Bio Inc.

2.63▲+0.50%post 2.63

Price

8.91▲+0.47%post 9.00

$106.1M

Mkt cap

$265.2M

—

Revenue

$54MQ4 FY25

OKUR2.63▲+0.50%vsQTTB8.91▲+0.47%ClosedOct 30 '26